Masimo Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 49/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 182.48.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Masimo Corp's Score
Industry at a Glance
Industry Ranking
49 / 208
Overall Ranking
132 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
10
analysts
Buy
Current Rating
182.480
Target Price
+29.56%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Masimo Corp Highlights
StrengthsRisks
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -12.62, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 60.04M shares, decreasing 6.78% quarter-over-quarter.
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Ticker SymbolMASI
CompanyMasimo Corp
CEOSzyman (Catherine M)
Websitehttps://www.masimo.com/
FAQs
What is the current price of Masimo Corp (MASI)?
The current price of Masimo Corp (MASI) is 134.040.
What is the symbol of Masimo Corp?
The ticker symbol of Masimo Corp is MASI.
What is the 52-week high of Masimo Corp?
The 52-week high of Masimo Corp is 194.880.
What is the 52-week low of Masimo Corp?
The 52-week low of Masimo Corp is 132.900.
What is the market capitalization of Masimo Corp?
The market capitalization of Masimo Corp is 7.12B.
What is the net income of Masimo Corp?
The net income of Masimo Corp is -304.90M.
Is Masimo Corp (MASI) currently rated as Buy, Hold, or Sell?
According to analysts, Masimo Corp (MASI) has an overall rating of Buy, with a price target of 182.480.
What is the Earnings Per Share (EPS TTM) of Masimo Corp (MASI)?
The Earnings Per Share (EPS TTM) of Masimo Corp (MASI) is -10.624.